India's Pharma FDI Concern Centers On Future Drug Needs, Official Says
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry appears to be a special concern of the government's focus on foreign direct investment because of a fear that even the compulsory-licensing provision might not help supply a national drug need.